Is CME Group Inc (CME) overvalued? · P/E 22, rev $3.59B
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
This page asks whether CME Group Inc (CME) looks expensive on cached numbers — not a short thesis.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
CME currently screens at market cap $91.25B and trailing P/E 21.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CME 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CME stock page for the full model, not this heading.
Not investment advice.